Glucagon-like peptide-1 agonists (GLP-1) are a class of medications that can be extremely effective at reducing blood sugar and A1C levels for those with type 2 diabetes
decline in the number of bariatric surgeries performed across the United States , which researchers attributed largely to the widespread availability of GLP-1 medications and weight management programs
The triple receptor mechanism targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
While this medication can help control hunger, regular physical activity may boost the medications weight-loss effects
May help improve diabetes, atherosclerotic plaque and even diabetic neuropathy ( through improved glucose utilization and Myelin sheath protection) Anti-Aging/Neurotransmitter Support: ALA is an antioxidant and also plays a synergistic role in recharging other antioxidants such as vitamin C, vitamin E, CoQ10 and glutathione